New York & Company, Inc. 4
4 · New York & Company, Inc. · Filed Jul 14, 2017
Insider Transaction Report
Form 4
Worthington John M
President and COO
Transactions
- Disposition to Issuer
Stock Appreciation Rights
2017-06-29−150,000→ 0 totalExercise: $2.60Exp: 2025-08-25→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Appreciation Rights
2017-06-29−750,000→ 0 totalExercise: $3.16Exp: 2024-11-03→ Common Stock (750,000 underlying) - Award
Stock Appreciation Rights
2017-06-29+381,148→ 381,148 totalExercise: $1.36Exp: 2024-11-03→ Common Stock (381,148 underlying) - Award
Stock Appreciation Rights
2017-06-29+91,935→ 91,935 totalExercise: $1.36Exp: 2025-08-25→ Common Stock (91,935 underlying)
Footnotes (6)
- [F1]Each Stock Appreciation Right (SAR) represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
- [F2]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program as more fully described in the Schedule TO, filed with the Securities and Exchange Commission on June 1, 2017. The reporting person was previously awarded SARs which were exercisable as follows: 187,500 on November 3, 2015, 187,500 on November 3, 2016, 187,500 on November 3, 2017, and 187,500 on November 3, 2018.
- [F3]In exchange for each cancelled award pursuant to the Company's Stock Appreciation Right and Option Exchange Program, the reporting person received a replacement award for a lesser number of SARs with an equal fair value and an exercise price equal to the closing price of the Company's common stock as reported on the New York Stock Exchange on June 29, 2017.
- [F4]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 95,287 on November 3, 2017, 190,574 on June 29, 2018, and 95,287 on November 3, 2018.
- [F5]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 37,500 on August 25, 2016, 37,500 on August 25, 2017, and 75,000 on August 25, 2018.
- [F6]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 22,983 on August 25, 2017, 22,983 on June 29, 2018, and 45,969 on August 25, 2018.